ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01712217
Recruitment Status : Completed
First Posted : October 23, 2012
Last Update Posted : January 19, 2018
Sponsor:
Information provided by (Responsible Party):
Astex Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2016
  Actual Study Completion Date : May 16, 2017
  Certification/Extension First Submitted : January 15, 2018